Home >> Medical Devices >> Food & Beverage >>

Global Cervical Cancer Diagnostic Testing Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Published: Oct-2018 | Format: PDF | Global Info Research | Number of pages: 132 | Code: MRS - 387539

Cervical cancer is the abnormal growth of cancerous cells in the tissues of the cervix. Cervical cancer is caused due to uncontrolled division of abnormal or cancerous cell growth in cervix region (lower uterus part) that leads to vagina in female reproductive tract. 



Scope of the Report:

This report focuses on the Cervical Cancer Diagnostic Testing in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

North America accounted for the largest share of the global market, followed by Europe. 

Asia-Pacific is expected to register a higher growth rate during the forecast period, owing to huge investment opportunities in this region. 

The worldwide market for Cervical Cancer Diagnostic Testing is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.



Market Segment by Manufacturers, this report covers

    F. Hoffmann-La Roche

    GlaxoSmithKline

    Merck

    Advaxis Immunotherapies

    Bionor Pharma

    Dendreon Corporation

    Inovio Pharmaceuticals

    ISA Pharmaceuticals

    Otsuka Pharmaceuticals

    Profectus Biosciences

    Virometix

    Hologic



Market Segment by Regions, regional analysis covers

    North America (United States, Canada and Mexico)

    Europe (Germany, France, UK, Russia and Italy)

    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

    South America (Brazil, Argentina, Colombia etc.)

    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)



Market Segment by Type, covers

    Pap Testing

    HPV Testing

    Colposcopy

    Cervical Biopsies



Market Segment by Applications, can be divided into

    Hospitals

    Cancer Palliative care clinics

    Diagnostic centers

    Pharmacies



There are 15 Chapters to deeply display the global Cervical Cancer Diagnostic Testing market.

Chapter 1, to describe Cervical Cancer Diagnostic Testing Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Cervical Cancer Diagnostic Testing, with sales, revenue, and price of Cervical Cancer Diagnostic Testing, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Cervical Cancer Diagnostic Testing, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Cervical Cancer Diagnostic Testing market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Cervical Cancer Diagnostic Testing sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents



1 Market Overview

    1.1 Cervical Cancer Diagnostic Testing Introduction

    1.2 Market Analysis by Type

        1.2.1 Pap Testing

        1.2.2 HPV Testing

        1.2.3 Colposcopy

        1.2.4 Cervical Biopsies

    1.3 Market Analysis by Applications

        1.3.1 Hospitals

        1.3.2 Cancer Palliative care clinics

        1.3.3 Diagnostic centers

        1.3.4 Pharmacies

    1.4 Market Analysis by Regions

        1.4.1 North America (United States, Canada and Mexico)

            1.4.1.1 United States Market States and Outlook (2013-2023)

            1.4.1.2 Canada Market States and Outlook (2013-2023)

            1.4.1.3 Mexico Market States and Outlook (2013-2023)

        1.4.2 Europe (Germany, France, UK, Russia and Italy)

            1.4.2.1 Germany Market States and Outlook (2013-2023)

            1.4.2.2 France Market States and Outlook (2013-2023)

            1.4.2.3 UK Market States and Outlook (2013-2023)

            1.4.2.4 Russia Market States and Outlook (2013-2023)

            1.4.2.5 Italy Market States and Outlook (2013-2023)

        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

            1.4.3.1 China Market States and Outlook (2013-2023)

            1.4.3.2 Japan Market States and Outlook (2013-2023)

            1.4.3.3 Korea Market States and Outlook (2013-2023)

            1.4.3.4 India Market States and Outlook (2013-2023)

            1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

        1.4.4 South America, Middle East and Africa

            1.4.4.1 Brazil Market States and Outlook (2013-2023)

            1.4.4.2 Egypt Market States and Outlook (2013-2023)

            1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

            1.4.4.4 South Africa Market States and Outlook (2013-2023)

            1.4.4.5 Nigeria Market States and Outlook (2013-2023)

    1.5 Market Dynamics

        1.5.1 Market Opportunities

        1.5.2 Market Risk

        1.5.3 Market Driving Force

2 Manufacturers Profiles

    2.1 F. Hoffmann-La Roche

        2.1.1 Business Overview

        2.1.2 Cervical Cancer Diagnostic Testing Type and Applications

            2.1.2.1 Product A

            2.1.2.2 Product B

        2.1.3 F. Hoffmann-La Roche Cervical Cancer Diagnostic Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.2 GlaxoSmithKline

        2.2.1 Business Overview

        2.2.2 Cervical Cancer Diagnostic Testing Type and Applications

            2.2.2.1 Product A

            2.2.2.2 Product B

        2.2.3 GlaxoSmithKline Cervical Cancer Diagnostic Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.3 Merck

        2.3.1 Business Overview

        2.3.2 Cervical Cancer Diagnostic Testing Type and Applications

            2.3.2.1 Product A

            2.3.2.2 Product B

        2.3.3 Merck Cervical Cancer Diagnostic Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.4 Advaxis Immunotherapies

        2.4.1 Business Overview

        2.4.2 Cervical Cancer Diagnostic Testing Type and Applications

            2.4.2.1 Product A

            2.4.2.2 Product B

        2.4.3 Advaxis Immunotherapies Cervical Cancer Diagnostic Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.5 Bionor Pharma

        2.5.1 Business Overview

        2.5.2 Cervical Cancer Diagnostic Testing Type and Applications

            2.5.2.1 Product A

            2.5.2.2 Product B

        2.5.3 Bionor Pharma Cervical Cancer Diagnostic Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.6 Dendreon Corporation

        2.6.1 Business Overview

        2.6.2 Cervical Cancer Diagnostic Testing Type and Applications

            2.6.2.1 Product A

            2.6.2.2 Product B

        2.6.3 Dendreon Corporation Cervical Cancer Diagnostic Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.7 Inovio Pharmaceuticals

        2.7.1 Business Overview

        2.7.2 Cervical Cancer Diagnostic Testing Type and Applications

            2.7.2.1 Product A

            2.7.2.2 Product B

        2.7.3 Inovio Pharmaceuticals Cervical Cancer Diagnostic Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.8 ISA Pharmaceuticals

        2.8.1 Business Overview

        2.8.2 Cervical Cancer Diagnostic Testing Type and Applications

            2.8.2.1 Product A

            2.8.2.2 Product B

        2.8.3 ISA Pharmaceuticals Cervical Cancer Diagnostic Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.9 Otsuka Pharmaceuticals

        2.9.1 Business Overview

        2.9.2 Cervical Cancer Diagnostic Testing Type and Applications

            2.9.2.1 Product A

            2.9.2.2 Product B

        2.9.3 Otsuka Pharmaceuticals Cervical Cancer Diagnostic Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.10 Profectus Biosciences

        2.10.1 Business Overview

        2.10.2 Cervical Cancer Diagnostic Testing Type and Applications

            2.10.2.1 Product A

            2.10.2.2 Product B

        2.10.3 Profectus Biosciences Cervical Cancer Diagnostic Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.11 Virometix

        2.11.1 Business Overview

        2.11.2 Cervical Cancer Diagnostic Testing Type and Applications

            2.11.2.1 Product A

            2.11.2.2 Product B

        2.11.3 Virometix Cervical Cancer Diagnostic Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

    2.12 Hologic

        2.12.1 Business Overview

        2.12.2 Cervical Cancer Diagnostic Testing Type and Applications

            2.12.2.1 Product A

            2.12.2.2 Product B

        2.12.3 Hologic Cervical Cancer Diagnostic Testing Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Cervical Cancer Diagnostic Testing Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    3.1 Global Cervical Cancer Diagnostic Testing Sales and Market Share by Manufacturer (2016-2017)

    3.2 Global Cervical Cancer Diagnostic Testing Revenue and Market Share by Manufacturer (2016-2017)

    3.3 Market Concentration Rate

        3.3.1 Top 3 Cervical Cancer Diagnostic Testing Manufacturer Market Share in 2017

        3.3.2 Top 6 Cervical Cancer Diagnostic Testing Manufacturer Market Share in 2017

    3.4 Market Competition Trend

4 Global Cervical Cancer Diagnostic Testing Market Analysis by Regions

    4.1 Global Cervical Cancer Diagnostic Testing Sales, Revenue and Market Share by Regions

        4.1.1 Global Cervical Cancer Diagnostic Testing Sales and Market Share by Regions (2013-2018)

        4.1.2 Global Cervical Cancer Diagnostic Testing Revenue and Market Share by Regions (2013-2018)

    4.2 North America Cervical Cancer Diagnostic Testing  Sales and Growth Rate (2013-2018)

    4.3 Europe Cervical Cancer Diagnostic Testing  Sales and Growth Rate (2013-2018)

    4.4 Asia-Pacific Cervical Cancer Diagnostic Testing  Sales and Growth Rate (2013-2018)

    4.5 South America Cervical Cancer Diagnostic Testing  Sales and Growth Rate (2013-2018)

    4.6 Middle East and Africa Cervical Cancer Diagnostic Testing  Sales and Growth Rate (2013-2018)

5 North America Cervical Cancer Diagnostic Testing by Countries

    5.1 North America Cervical Cancer Diagnostic Testing Sales, Revenue and Market Share by Countries

        5.1.1 North America Cervical Cancer Diagnostic Testing Sales and Market Share by Countries (2013-2018)

        5.1.2 North America Cervical Cancer Diagnostic Testing Revenue and Market Share by Countries (2013-2018)

    5.2 United States Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

    5.3 Canada Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

    5.4 Mexico Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

6 Europe Cervical Cancer Diagnostic Testing by Countries

    6.1 Europe Cervical Cancer Diagnostic Testing Sales, Revenue and Market Share by Countries

        6.1.1 Europe Cervical Cancer Diagnostic Testing Sales and Market Share by Countries (2013-2018)

        6.1.2 Europe Cervical Cancer Diagnostic Testing Revenue and Market Share by Countries (2013-2018)

    6.2 Germany Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

    6.3 UK Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

    6.4 France Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

    6.5 Russia Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

    6.6 Italy Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

7 Asia-Pacific Cervical Cancer Diagnostic Testing by Countries

    7.1 Asia-Pacific Cervical Cancer Diagnostic Testing Sales, Revenue and Market Share by Countries

        7.1.1 Asia-Pacific Cervical Cancer Diagnostic Testing Sales and Market Share by Countries (2013-2018)

        7.1.2 Asia-Pacific Cervical Cancer Diagnostic Testing Revenue and Market Share by Countries (2013-2018)

    7.2 China Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

    7.3 Japan Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

    7.4 Korea Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

    7.5 India Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

    7.6 Southeast Asia Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

8 South America Cervical Cancer Diagnostic Testing by Countries

    8.1 South America Cervical Cancer Diagnostic Testing Sales, Revenue and Market Share by Countries

        8.1.1 South America Cervical Cancer Diagnostic Testing Sales and Market Share by Countries (2013-2018)

        8.1.2 South America Cervical Cancer Diagnostic Testing Revenue and Market Share by Countries (2013-2018)

    8.2 Brazil Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

    8.3 Argentina Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

    8.4 Colombia Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

9 Middle East and Africa Cervical Cancer Diagnostic Testing by Countries

    9.1 Middle East and Africa Cervical Cancer Diagnostic Testing Sales, Revenue and Market Share by Countries

        9.1.1 Middle East and Africa Cervical Cancer Diagnostic Testing Sales and Market Share by Countries (2013-2018)

        9.1.2 Middle East and Africa Cervical Cancer Diagnostic Testing Revenue and Market Share by Countries (2013-2018)

    9.2 Saudi Arabia Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

    9.3 UAE Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

    9.4 Egypt Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

    9.5 Nigeria Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

    9.6 South Africa Cervical Cancer Diagnostic Testing Sales and Growth Rate (2013-2018)

10 Global Cervical Cancer Diagnostic Testing Market Segment by Type

    10.1 Global Cervical Cancer Diagnostic Testing Sales, Revenue and Market Share by Type (2013-2018)

        10.1.1 Global Cervical Cancer Diagnostic Testing Sales and Market Share by Type (2013-2018)

        10.1.2 Global Cervical Cancer Diagnostic Testing Revenue and Market Share by Type (2013-2018)

    10.2 Pap Testing Sales Growth and Price

        10.2.1 Global Pap Testing Sales Growth (2013-2018)

        10.2.2 Global Pap Testing Price (2013-2018)

    10.3 HPV Testing Sales Growth and Price

        10.3.1 Global HPV Testing Sales Growth (2013-2018)

        10.3.2 Global HPV Testing Price (2013-2018)

    10.4 Colposcopy Sales Growth and Price

        10.4.1 Global Colposcopy Sales Growth (2013-2018)

        10.4.2 Global Colposcopy Price (2013-2018)

    10.5 Cervical Biopsies Sales Growth and Price

        10.5.1 Global Cervical Biopsies Sales Growth (2013-2018)

        10.5.2 Global Cervical Biopsies Price (2013-2018)

11 Global Cervical Cancer Diagnostic Testing Market Segment by Application

    11.1 Global Cervical Cancer Diagnostic Testing Sales Market Share by Application (2013-2018)

    11.2 Hospitals Sales Growth (2013-2018)

    11.3 Cancer Palliative care clinics Sales Growth (2013-2018)

    11.4 Diagnostic centers Sales Growth (2013-2018)

    11.5 Pharmacies Sales Growth (2013-2018)

12 Cervical Cancer Diagnostic Testing Market Forecast (2018-2023)

    12.1 Global Cervical Cancer Diagnostic Testing Sales, Revenue and Growth Rate (2018-2023)

    12.2 Cervical Cancer Diagnostic Testing Market Forecast by Regions (2018-2023)

        12.2.1 North America Cervical Cancer Diagnostic Testing Market Forecast (2018-2023)

        12.2.2 Europe Cervical Cancer Diagnostic Testing Market Forecast (2018-2023)

        12.2.3 Asia-Pacific Cervical Cancer Diagnostic Testing Market Forecast (2018-2023)

        12.2.4 South America Cervical Cancer Diagnostic Testing Market Forecast (2018-2023)

        12.2.5 Middle East and Africa Cervical Cancer Diagnostic Testing Market Forecast (2018-2023)

    12.3 Cervical Cancer Diagnostic Testing Market Forecast by Type (2018-2023)

        12.3.1 Global Cervical Cancer Diagnostic Testing Sales Forecast by Type (2018-2023)

        12.3.2 Global Cervical Cancer Diagnostic Testing Market Share Forecast by Type (2018-2023)

    12.4 Cervical Cancer Diagnostic Testing Market Forecast by Application (2018-2023)

        12.4.1 Global Cervical Cancer Diagnostic Testing Sales Forecast by Application (2018-2023)

        12.4.2 Global Cervical Cancer Diagnostic Testing Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

    13.1 Sales Channel

        13.1.1 Direct Marketing

        13.1.2 Indirect Marketing

        13.1.3 Marketing Channel Future Trend

    13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

    15.1 Methodology

    15.2 Data Source


                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)3480 View Pricing